Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung

BACKGROUND: Despite approvals of immune checkpoint inhibitors in both small cell and non-small cell lung cancers, the role of immunotherapy in large cell neuroendocrine carcinoma (LCNEC) in lung is undefined. METHODS: Using the National Cancer Database (NCDB), Stage IV lung LCNEC cases diagnosed fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Komiya, Takefumi, Ravindra, Neema, Powell, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190341/
https://www.ncbi.nlm.nih.gov/pubmed/33639649
http://dx.doi.org/10.31557/APJCP.2021.22.2.365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190341/
https://www.ncbi.nlm.nih.gov/pubmed/33639649
http://dx.doi.org/10.31557/APJCP.2021.22.2.365

Ejemplares similares